Pan-Canadian consensus recommendations for proton beam therapy access in Canada

Autor: Gunita Mitera, Derek Tsang, Boyd McCurdy, Karen Goddard, Annie Ebacher, Tim Craig, Jonathan Greenland, Staci Kentish, Rashmi Koul, Natalie Logie, Mélanie Morneau, Andra Morrison, Larry Pan, Jason Pantarotto, Sophie Foxcroft, Jonathan Sussman, Robert Thompson, Scott Tyldesley, Philip Wright, Sarah Hicks, Erika Brown, Samir Patel
Rok vydání: 2022
Předmět:
Zdroj: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 176
ISSN: 1879-0887
Popis: Proton Beam Therapy (PBT)is a treatment option for select cancer patients. It is currently not available in Canada. Assessment and referral processes for out-of-country treatment for eligible patients vary by jurisdiction, leading to variability in access to this treatment for Canadian cancer patients. The purpose of this initiative was to develop a framework document to inform consistent and equitable PBT access for appropriate patients through the creation of pan-Canadian PBT access consensus recommendations.A modified Delphiprocess was used to develop pan-Canadian recommendations with input from 22 PBT clinical and administrative experts across all provinces, external peer-review by provincial cancer and system partners, and feedback from a targeted community consultation. This was conducted by electronic survey and live discussion. Consensus threshold was set at 70% agreement.Fourconsensus rounds resulted in a final set of 27 recommendations divided into three categories: patient eligibility (n = 9); program level (n = 10); and system level (n = 8). Patient eligibility included: anatomic site (n = 4), patient characteristics (n = 3), clinical efficacy (n = 2). Program level included: regulatory and staff requirements (n = 5), equipment and technologies (n = 4), quality assurance (n = 1). System level included: referral process (n = 5), costing, budget impact and quality adjusted life years (n = 2), eligible patient estimates (n = 1). Recommendations were released nationally in June 2021 and distributed to all 43 cancer programs in Canada.A pan-Canadian consensus-building approach was successful in creating an evidence-based, peer-reviewed suite of recommendations thatsupportapplication of consistent clinical criteria to inform treatment options, facility set-up and access to high quality proton therapy.
Databáze: OpenAIRE